Director · ACADIA PHARMACEUTICALS INC · ACADIA PHARMACEUTICALS INC — Director Stock Options (Right to Buy)
Side
A
Value
—
Shares
16.0K
Price
—
Executed
May 29, 2026
Disclosed
Jun 1, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
May 29 executedJun 1, 2026 disclosed
ACAD · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
ACADIA PHARMACEUTICALS INC — Director Stock Options (Right to Buy)
Ticker
ACAD
Shares
16.0K
Price per share
$0
Execution date (reported)
May 29, 2026
Owned after transaction
16.0K shares
Days from execution to publication
3
What this establishes
Ndu Adora filed this Form 4 reporting a grant or award of ACAD on May 29, 2026. It became public on Jun 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Ndu Adoracik:0001865210
Issuer
ACADIA PHARMACEUTICALS INCcik:0001070494
Revision history · 0
No field has changed since this record was first ingested.
